Echo IQ Limited (ASX:EIQ)

ALERT: Price-sensitive ASX Announcement for EIQ

Current share price for EIQ : $1.480 -0.11 (-6.92%)⁺

Announcement

Echo IQ Raises A$110m via Institutional Placement

Release

1 Jul 2026 9:15AM

Price at Release

$1.590

Full Release

Summary

Echo IQ Limited announced a successful institutional placement of approximately A$110 million at A$1.45 per share, intended to fund US commercial expansion and accelerate the development of its AI product pipeline. The placement, which represents approximately 11.5% of Echo IQ's current issued capital, was priced at an 8.8% discount to the last traded price and was well-supported by both existing and new institutional investors. Net proceeds will be used to strengthen Echo IQ's balance sheet, accelerate the deployment of EchoSolv in the US, and continue investment in product development and strategic opportunities. This move follows significant progress including FDA clearance for EchoSolv Aortic Stenosis and strategic partnerships with major healthcare organizations. Echo IQ aims to leverage this capital to expand its cardiovascular AI platform and enhance its market presence.

Key Points

Echo IQ Limited raises ~A$110 million through institutional placement.
Placement priced at A$1.45 per share, an 8.8% discount to the last traded price.
Approximately 11.5% of current issued capital is represented by the new shares.
Funds will be used for US commercial expansion and product development.
Placement supports further deployment and development of EchoSolv platform.
Strategic partnerships established with Mayo Clinic and Pro Medicus.
FDA clearance achieved for EchoSolv Aortic Stenosis.
The placement reflects confidence in Echo IQ's growth strategy and market opportunities.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.